MO Diaz
- Hematology top 2%
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 8
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 8
- Genomic variations and chromosomal abnormalities 3
-
- Acute Lymphoblastic Leukemia research 8
-
- interferon and immune responses 3
-
- Cytokine Signaling Pathways and Interactions 4
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- JD RowleyRichard A. LarsonJ Pedersen-BjergaardPreben PhilipMM Le BeauMJ ThirmanHirofumi KobayashiJ D Rowley
- Journals
- Blood (12 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesUruguayUnited Kingdom
In The Last Decade
MO Diaz
22 papers receiving 911 citations
Peers
Comparison fields: 5 of 46
- Hematology 493
- Genetics 133
- Public Health, Environmental and Occupational Health 300
- Immunology 183
- Oncology 197
Countries citing papers authored by MO Diaz
This map shows the geographic impact of MO Diaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MO Diaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MO Diaz more than expected).
Fields of papers citing papers by MO Diaz
This network shows the impact of papers produced by MO Diaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MO Diaz. The network helps show where MO Diaz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside MO Diaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 7 | |
| 2 | 1996 | 36 | |
| 3 | Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells. | 1996 | 7 |
| 4 | 1994 | 13 | |
| 5 | Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study. | 1994 | 13 |
| 6 | 1994 | 6 | |
| 7 | 1994 | 87 | |
| 8 | 1994 | 24 | |
| 9 | 1993 | 64 | |
| 10 | 1993 | 256 | |
| 11 | 1993 | 15 | |
| 12 | 1993 | 23 | |
| 13 | 1992 | 68 | |
| 14 | 1992 | 2 | |
| 15 | 1991 | 56 | |
| 16 | 1990 | 47 | |
| 17 | 1987 | 5 | |
| 18 | 1987 | 21 | |
| 19 | 1987 | 70 | |
| 20 | 1986 | 26 |
About MO Diaz
MO Diaz is a scholar working on Hematology, Genetics and Immunology, having authored 22 papers that have together received 929 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Cytokine Signaling Pathways and Interactions (4 papers), interferon and immune responses (3 papers), Genomic variations and chromosomal abnormalities (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (493 citations), Genetics (133 citations) and Public Health, Environmental and Occupational Health (300 citations). MO Diaz has collaborated with scholars based in United States, Uruguay and United Kingdom. Frequent co-authors include JD Rowley, Richard A. Larson, J Pedersen-Bjergaard, Preben Philip, MM Le Beau, MM Le Beau, MJ Thirman, Hirofumi Kobayashi, J D Rowley and Michelle M. Le Beau. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, The Journal of Immunology and Journal of Interferon & Cytokine Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.